The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: A case-control study, comorbidities, and meta-analysis of 16,786 subjects

Bipolar Disorders

Volumn 17, Issue 1, 2015, Pages 27-38

  González Castro, Thelma Beatriz ^a   Nicolini, Humberto ^b,c   Lanzagorta, Nuria ^b   López Narváez, Lilia ^d,e   Genis, Alma ^c   Pool García, Sherezada ^f   Tovilla Zárate, Carlos Alfonso ^a  

^a UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^b Grupo de Estudios Médicos Y Familiares Carracci   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d General Hospital of Yajalon   (Mexico)

^e CIGEN   (Mexico)

^f Hospital General de Comalcalco   (Mexico)

Author keywords

Bipolar disorder; Brain derived neurotrophic factor (BDNF) gene; Meta analysis; Mexican population

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; DIPEPTIDE; VALYLVALINE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDLINE; MENTAL DISEASE; MENTAL PATIENT; META ANALYSIS; MEXICAN; MIDDLE AGED; PRIORITY JOURNAL; PUBLISHING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SYSTEMATIC REVIEW (TOPIC); WEB OF SCIENCE; YOUNG ADULT; GENETICS; MEXICO; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SUICIDE;

ADULT; BIPOLAR DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DIPEPTIDES; FEMALE; GENOTYPE; HUMANS; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDE;

EID: 84921543877     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12227     Document Type: Article

References (52)

1. Hu M-C, Lee S-Y, Wang T-Y et al. Association study of DRD2 and MAOA genes with subtyped alcoholism comorbid with bipolar disorder in Han Chinese. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40: 144-148.
2. Vincze I, Perroud N, Buresi C et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord 2008; 10: 580-587.
3. Skibinska M, Hauser J, Czerski PM et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5: 215-220.
4. Carrard A, Salzmann A, Perroud N et al. Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism. Brain Behav 2011; 1: 119-124.
5. Hosang GM, Uher R, Keers R et al. Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J Affect Disord 2010; 125: 345-349.
6. Ball S, Marangell LB, Lipsius S, Russell JM. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 2013; 43: 217-221.
7. Boiocchi C, Maggioli E, Zorzetto M et al. Brain-derived neurotrophic factor gene variants and Alzheimer disease: an association study in an Alzheimer disease Italian population. Rejuvenation Res 2013; 16: 57-66.
8. Dai L, Wang D, Meng H et al. Association between the BDNF G196A and C270T polymorphisms and Parkinson's disease: a meta-analysis. Int J Neurosci 2013; 123: 675-683.
9. Hallden S, Sjogren M, Hedblad B et al. Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers. Heart 2013; 99: 949-953.
10. Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol 2013; 100: 15-29.
11. Illi A, Viikki M, Poutanen O et al. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. Psychiatr Genet 2013; 23: 33-35.
12. Katsuki A, Yoshimura R, Kishi T et al. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD). CNS Spectr 2012; 17: 155-163.
13. Lotrich FE, Albusaysi S, Ferrell RE. Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-alpha treatment. Neuropsychopharmacology 2013; 38: 985-995.
14. Ma L, Chen Y, Wang L et al. Brain-derived neurotrophic factor Val66Met polymorphism is not associated with primary dystonia in a Chinese population. Neurosci Lett 2013; 533: 100-103.
15. Min JA, Lee HJ, Lee SH et al. Gender-specific effects of brain-derived neurotrophic factor Val66Met polymorphism and childhood maltreatment on anxiety. Neuropsychobiology 2013; 67: 6-13.
16. Seifuddin F, Mahon PB, Judy J et al. Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2012; 5: 508-518.
17. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007; 17: 165-170.
18. Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care 2011; 25: 1-2.
19. Wang Z, Li Z, Chen J et al. Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population. Genes Brain Behav 2012; 11: 524-528.
20. Kavvoura FK, Ioannidis JP. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 2008; 123: 1-14.
21. Gonzalez-Castro TB, Tovilla-Zarate C, Juarez-Rojop I et al. Association of the 5HTR2A gene with suicidal behavior: case-control study and updated meta-analysis. BMC Psychiatry 2013; 47: 1665-1672.
22. Azorin JM, Bellivier F, Kaladjian A et al. Characteristics and profiles of bipolar I patients according to age-at-onset: findings from an admixture analysis. J Affect Disord 2013; 150: 993-1000.
23. Geoffroy PA, Etain B, Scott J, et al. Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset. J Physiol Paris 2013; 107: 278-285.
24. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
25. Tovilla-Zarate C, Medellin BC, Fresan A et al. No association between catechol-o-methyltransferase Val108/158Met polymorphism and schizophrenia or its clinical symptomatology in a Mexican population. Mol Biol Rep 2013; 40: 2053-2058.
26. Tang J, Xiao L, Shu C et al. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci Lett 2008; 433: 98-102.
27. Xu J, Liu Y, Wang P et al. Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet B Neuropsychiatr Genet 2010; 5: 275-279.
28. Oswald P, Del-Favero J, Massat I et al. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet B Neuropsychiatr Genet 2004; 15: 34-35.
29. Hong CJ, Huo SJ, Yen FC et al. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186-189.
30. Nakata K, Ujike H, Sakai A et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17-20.
31. Lee SY, Chen SL, Wang YS et al. COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder. Behav Brain Res 2013; 237: 243-248.
32. Lee SY, Chen SL, Chen SH et al. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 382-387.
33. Min HJ, Cho HS, Kim SJ et al. Association of the brain-derived neurotrophic factor gene and clinical features of bipolar disorder in Korea. Clin Psychopharmacol Neurosci 2012; 10: 163-167.
34. Lohoff FW, Sander T, Ferraro TN et al. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 5: 51-53.
35. Tramontina J, Frey BN, Andreazza AC et al. Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry 2007; 12: 230-231.
36. Pae CU, Chiesa A, Porcelli S et al. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology 2012; 65: 1-11.
37. Kunugi H, Iijima Y, Tatsumi M et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 2004; 56: 376-378.
38. Green EK, Raybould R, Macgregor S et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry 2006; 188: 21-25.
39. Schumacher J, Jamra RA, Becker T et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-314.
40. Kim B, Kim CY, Hong JP et al. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 2008; 58: 97-103.
41. Miller S, Hallmayer J, Wang PW et al. Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. J Psychiatr Res 2013; 47: 252-258.
42. Neves FS, Malloy-Diniz L, Romano-Silva MA et al. The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord 2011; 131: 307-311.
43. Kawashima K, Ikeda M, Kishi T et al. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr Res 2009; 112: 72-79.
44. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 2011; 16: 960-972.
45. Chen L, Lawlor DA, Lewis SJ et al. Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2008; 5: 814-821.
46. Gyekis JP, Yu W, Dong S et al. No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis. Am J Med Genet B Neuropsychiatr Genet 2013; 1: 61-70.
47. Verhagen M, van der Meij A, van Deurzen PA et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010; 15: 260-271.
48. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11: 1169-1180.
49. Bauer MS, Altshuler L, Evans DR et al. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005; 85: 301-315.
50. Latalova K, Prasko J, Kamaradova D, Sedlackova J, Ociskova M. Comorbidity bipolar disorder and personality disorders. Neuro Endocrinol Lett 2013; 34: 1-8.
51. Agius M, Lee J, Gardner J, Wotherspoon D. Bipolar II disorder and borderline personality disorder - co-morbidity or spectrum? Psychiatr Danub 2012; 24: S197-S201.
52. Rakofsky JJ, Ressler KJ, Dunlop BW. BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol Psychiatry 2012; 17: 22-35.